SEC CIK 1515709
Gangestad Nicholas C
Reported ownership across 4 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| MMMview stock → | 44,046.32 | 2020-02-04 |
| Gview stock → | 15,334 | 2026-04-23 |
| ROKview stock → | 10,557 | 2024-03-06 |
| NUEview stock → | 4,315 | 2026-06-01 |
Position History — ROK
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — ROK
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2024-03-06 | Open-market sale | 109 | $288.20 | 10,557 |
| 2024-03-06 | Open-market sale | 1,551 | $287.65 | 10,666 |
| 2024-03-04 | Open-market sale | 118 | $288.46 | 12,217 |
| 2024-03-04 | Open-market sale | 1,871 | $288.15 | 12,335 |
| 2024-03-01 | Option exercise (derivative) | 5,309 | $0.00 | 0 |
| 2024-03-01 | Option exercise | 5,309 | $0.00 | 14,206 |
| 2023-12-11 | Open-market sale | 517 | $279.68 | 8,957 |
| 2023-12-11 | Open-market sale | 60 | $280.12 | 8,897 |
| 2023-12-09 | Option exercise (derivative) | 1,232 | $0.00 | 2,464 |
| 2023-12-09 | Option exercise | 1,232 | $0.00 | 9,474 |
| 2023-12-08 | Open-market sale | 427 | $279.04 | 8,242 |
| 2023-12-07 | Option exercise (derivative) | 912 | $0.00 | 913 |
| 2023-12-07 | Option exercise | 912 | $0.00 | 8,669 |
| 2023-12-04 | Grant / award (derivative) | 3,435 | $0.00 | 3,435 |
| 2023-12-04 | Grant / award (derivative) | 11,175 | $0.00 | 11,175 |
| 2023-03-02 | Open-market sale | 210 | $294.67 | 7,757 |
| 2023-03-02 | Open-market sale | 1,765 | $294.20 | 7,967 |
| 2023-03-01 | Option exercise (derivative) | 5,308 | $0.00 | 5,309 |
| 2023-03-01 | Option exercise | 5,308 | $0.00 | 9,732 |
| 2022-12-09 | Grant / award (derivative) | 3,696 | $0.00 | 3,696 |
| 2022-12-09 | Grant / award (derivative) | 12,368 | $0.00 | 12,368 |
| 2022-12-08 | Open-market sale | 426 | $256.82 | 4,424 |
| 2022-12-07 | Option exercise (derivative) | 912 | $0.00 | 1,825 |
| 2022-12-07 | Option exercise | 912 | $0.00 | 4,850 |
| 2022-03-02 | Open-market sale | 1,870 | $270.33 | 3,938 |
| 2022-03-01 | Option exercise (derivative) | 5,308 | $0.00 | 10,617 |
| 2022-03-01 | Option exercise | 5,308 | $0.00 | 5,808 |
| 2021-12-07 | Grant / award (derivative) | 10,949 | $0.00 | 10,949 |
| 2021-12-07 | Grant / award (derivative) | 2,737 | $0.00 | 2,737 |
| 2021-05-03 | Open-market buy | 500 | $262.11 | 500 |
| 2021-03-01 | — | — | — | 0 |
| 2021-03-01 | Grant / award (derivative) | 15,925 | $0.00 | 15,925 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.